Emerald Trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

February, 2025

Emerald Trial

Jan 25, 2025, 16:19 | Science

Paolo Tarantino: Evolutions in the treatment of HER2+ breast cancer

Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared an article by Tess A. O'Meara…

Jan 13, 2025, 10:23 | Science

The Randomized Noninferiority Phase III EMERALD Trial on HER2+ Locally Advanced/Metastatic Breast Cancer

A recent paper by Toshinari Yamashita et al. was published in the Journal of Clinical…

Nov 5, 2024, 15:32 | Blog

Carmen Criscitiello: SERENA-2 and INAVO120 offering fresh insights on targeted approaches in MBC

Carmen Criscitiello, Medical Oncologist at IEO and Associate Professor at University of Milan, posted on…

Aug 30, 2024, 13:53 | Blog

Maryam Lustberg: Guide decision making between ESR1 vs PI3K targeting

Maryam Lustberg shared a post on X by Mridula George adding: "The question of sequencing…

All: 4 Posts: 1 - 100

'

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

'

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

'

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

'

Best of ASCOGI25

'

Egypt Cancer Society (ECS) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023